title: Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
authors.affiliation: Department of Hematology/Oncology, University of Münster, FRG.
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: S
authors.initials: S
authors.lastname: Blasius
authors.forename: P
authors.initials: P
authors.lastname: Koch
authors.forename: G
authors.initials: G
authors.lastname: Maschmeyer
authors.forename: C
authors.initials: C
authors.lastname: Tirier
authors.forename: H
authors.initials: H
authors.lastname: Sodomann
authors.forename: R
authors.initials: R
authors.lastname: Kuse
authors.forename: E
authors.initials: E
authors.lastname: Thiel
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005860:Germany, West; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D003520:Cyclophosphamide; D013866:Thioguanine; D003630:Daunorubicin